Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells. (Q39354487)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 May 2012

Language	Label	Description	Also known as
English	Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells.	scientific article published on 2 May 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Kunio Matsumoto

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Shinji Takeuchi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Junya Nakade

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Kenji Kita

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Takayuki Nakagawa

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Shigeki Nanjo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Takahiro Nakamura

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Manabu Soda

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Hiroyuki Mano

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Toshimitsu Uenaka

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Seiji Yano

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

0 references

publication date

2 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Clinical Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

3592-3602

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22553343%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1158/1078-0432.CCR-08-0168

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2009.11.022

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39354487&oldid=1647778862"